Atlas Trials

Observational Multicenter Study in Patients Receiving Chemotherapy and Amivantamab for Metastatic Non-small Cell Lung Cancer

Clinical trial NCT07563205 · RECRUITING

Trial details

NCT number
NCT07563205
Sponsor
GFPC Investigation
Status
RECRUITING
Study type
OBSERVATIONAL
Non-Small Cell Lung CancerNon Small Cell Lung Cancer MetastaticNon Small Cell Lung Cancer NSCLCNon Small Cell Lung CarcinomaNSCLCEGFREGFR Exon 20 Insertion MutationEGFR Exon 19 Deletion MutationEGFR Exon 21 Mutation
Start date
2025-11-19
Primary completion
2027-11-19
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.